Clinical Trials Logo

Pediatric NAFLD clinical trials

View clinical trials related to Pediatric NAFLD.

Filter by:
  • None
  • Page 1

NCT ID: NCT03867487 Not yet recruiting - Clinical trials for Non-Alcoholic Fatty Liver Disease

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

SLIDE
Start date: May 1, 2024
Phase: Phase 2
Study type: Interventional

This study is a randomized, double-blind, placebo-controlled trial specifically designed to evaluate the preliminary feasibility, initial efficacy and safety of SGLT2 inhibitors for treating NAFLD in adolescents with obesity.